Immod Innovations, a speciality nutrition company, has introduced Cell Boost & Balance (CellBB), a next-generation liposomal immune and cellular health supplements range in the US market.
CellBB is a patented blend of bio-active liposomal phospholipids designed to enhance cellular health and promote immune balance.
The line harnesses a liposomal formulation derived from natural phospholipids sourced from egg yolks, ensuring stability in the digestive tract and maximising bioavailability.
Scientists and physicians have optimised the composition of CellBB extracts to mirror the bio-active phospholipids found in fertilised eggs and the developmental environment of chick embryos.
The first product in the CellBB product line includes Immune Equilibrium, available to customers on the firm’s website.
Immod Innovations CEO Jakub Staszak said: “We are excited to launch the CellBB supplement.
“Phospholipids are essential parts of every cell in our bodies, necessary for normal healthy function, including immunity and cellular regeneration.”
Cell Boost & Balance delivers optimised nutrients that promote healthy cell function, counterbalancing environmental stressors.
The phospholipids in CellBB are integral to the protective membranes surrounding our cells, playing a vital role in cell signalling.
Research has shown that these phospholipids stimulate natural killer (NK) cells of the immune system, essential for innate immunity and immune regulation, Immod Innovations said.
CellBB Immune Equilibrium provides essential ingredients that support healthy cellular membranes and balanced immunity.
Its small, easily consumable capsules are crafted from all-natural, sustainably sourced ingredients processed in advanced facilities.
The speciality nutrition company claimed that the product supports the body’s natural defences without causing side effects and is free from gluten and allergens.
Immod Innovations aims to enhance people’s health and well-being through optimised immunity solutions.
The company was founded following laboratory research conducted by scientists and physicians from Machavert Pharmaceuticals, inspired by Ovosan, a European supplement.
